Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
Background and Objectives: Female pattern hair loss (FPHL) is a common form of scalp hair loss that occurs in 38% of females. Currently, minoxidil solution is the only therapy approved by the US Food and Drug Administration, but many other treatments are used, including cyproterone acetate, spironol...
Guardado en:
Autores principales: | Alfredo Rossi, Francesca Magri, Andrea D'Arino, Flavia Pigliacelli, Marta Muscianese, Pierpaolo Leoncini, Gemma Caro, Alessandro Federico, Maria Caterina Fortuna, Marta Carlesimo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1d78e3e6b3a4537b041b1d20fde700c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efectos adversos de finasteride: mitos y realidades. Una revisión actualizada
por: Carreño-Orellana,Néstor, et al.
Publicado: (2016) -
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Kanamoto T, et al.
Publicado: (2012) -
Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
por: Irfan MM, et al.
Publicado: (2021) -
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
por: Turan-Vural E, et al.
Publicado: (2011) -
Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi T, et al.
Publicado: (2017)